Corneal Crosslinking
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by 40 Mm Treatment
Research Leaders
6 sponsors active, led by Glaukos Corporation
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
A Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System
Epi-on PiXL for the Treatment of Progressive Keratoconus.
Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus
Surface Ablation With Corneal Cross Linking in Mild Keratoconus
Advanced Cross Linking for Low-grade Myopia
Photorefractive Intrastromal Corneal Crosslinking as a Treatment for Low Grade Myopia
Research Network
Common Treatments
- 40 Mm Treatment1
- Epion Pixl In High Oxygen1
- Photorefractive Keratectomy With Corneal Crosslinking1
- Boss Imaging1
- Epioff Pixl1
Active Sponsors
- Glaukos Corporation4
- Umeå University4
- Negah Eye Center1
- Tehran University of Medical Sciences1
- Intelon Optics, Inc1
Top Investigators
Department of Clinical Sciences/Ophthalmology, Umeå University, Umeå, Sweden
Department of Clinical Sciences/Ophthalmology, Umeå University
Department of Clinical Sciences/Ophthalmology, Umeå University
Iran University of Medical Sciences
Related Conditions
- Eye Diseases3
- Keratoconus3
- Myopia2
- Scheimpflug Photography2
- Corneal Densitometry2